These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7751227)
1. Sundlof outlines vision for FDA to council. J Am Vet Med Assoc; 1995 Feb; 206(3):275-6. PubMed ID: 7751227 [No Abstract] [Full Text] [Related]
2. Use of FDA-approved drugs in veterinary medicine: prerogatives and responsibilities. Mann CJ J Am Vet Med Assoc; 1993 May; 202(10):1674-7;discussion 1684-92. PubMed ID: 8514581 [No Abstract] [Full Text] [Related]
3. Implications for the FDA/Center for Veterinary Medicine (CVM). Geyer RE J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592 [No Abstract] [Full Text] [Related]
4. A visit from the FDA. Brett J J Am Vet Med Assoc; 1994 May; 204(9):1319-20. PubMed ID: 8050959 [No Abstract] [Full Text] [Related]
5. Criteria for extra-label drug use debated at FDA Advisory Committee meeting. Raef TA J Am Vet Med Assoc; 1995 Jul; 207(1):10-1. PubMed ID: 7601683 [No Abstract] [Full Text] [Related]
6. FDA extra-label use policy: 1992 revisions. Guest GB; Solomon SM J Am Vet Med Assoc; 1993 May; 202(10):1620-3;discussion 1626-31. PubMed ID: 8514568 [No Abstract] [Full Text] [Related]
7. Current FDA policy on use of human-labeled drugs in animals. Teske RH J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570 [No Abstract] [Full Text] [Related]
8. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association. J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375 [No Abstract] [Full Text] [Related]
9. FDA responsibilities in regulation of drugs for use in animals: congressional perspective. Zeller M J Am Vet Med Assoc; 1993 May; 202(10):1609-12; discussion 1613-7. PubMed ID: 8514566 [No Abstract] [Full Text] [Related]
10. FDA backs legislation to restrict antimicrobial use. Cima G J Am Vet Med Assoc; 2009 Sep; 235(5):493-5. PubMed ID: 19731457 [No Abstract] [Full Text] [Related]
11. HSUS sues FDA to end preventive extralabel use. Nolen S J Am Vet Med Assoc; 1999 Jun; 214(11):1607. PubMed ID: 10363086 [No Abstract] [Full Text] [Related]
12. Compounding forum: FDA-CVM hears veterinarians' views. J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690 [No Abstract] [Full Text] [Related]
13. FDA establishes tolerances for tetracyclines in milk. J Am Vet Med Assoc; 1998 Oct; 213(7):946. PubMed ID: 9841236 [No Abstract] [Full Text] [Related]
14. Advisory committees tell FDA-CVM: restrict fluoroquinolone uses in food-producing animals. Gloyd JS J Am Vet Med Assoc; 1994 Jul; 205(1):19-20. PubMed ID: 7928541 [No Abstract] [Full Text] [Related]
15. FDA reaffirms position on extra-label use of ionophore drugs. J Am Vet Med Assoc; 1995 Oct; 207(7):828. PubMed ID: 7558998 [No Abstract] [Full Text] [Related]
16. Council stands firm on pharmaceutical compounding position. J Am Vet Med Assoc; 1992 Dec; 201(12):1821-2. PubMed ID: 1483896 [No Abstract] [Full Text] [Related]
17. Restrictions on antibiotics proposed by the FDA: a practitioner's point of view. Blohm WD Vet Med Small Anim Clin; 1978 May; 73(5):558, 560, 562, passim. PubMed ID: 249153 [No Abstract] [Full Text] [Related]
18. Foreign establishment registration and listing. Final rule. Food and Drug Administration, HHS Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289 [TBL] [Abstract][Full Text] [Related]
19. FDA seeks to clear up confusion about compounding. J Am Vet Med Assoc; 2003 Oct; 223(8):1103, 1106. PubMed ID: 14584731 [No Abstract] [Full Text] [Related]
20. Impact of the Animal Drug Availability Act on veterinary practitioners and the animal health industry. Troutman LM; Vaughn SD; Schmerfeld G; Beaulieu AJ J Am Vet Med Assoc; 1997 Jun; 210(11):1597-600. PubMed ID: 9170084 [No Abstract] [Full Text] [Related] [Next] [New Search]